Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FPRF3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,414.65 by the Defense Logistics Agency on August 25, 2025, for the supply of Nexplanon 68 mg implants. The contract carries an ultimate completion date of September 16, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
The Defense Logistics Agency utilizes the SPE2DB vehicle to maintain a robust supply chain of branded and generic prescription drugs, biologics, and medical consumables distributed to Department of Defense healthcare installations globally. DMS Pharmaceutical Group's portfolio of federal contracts demonstrates consistent capability in delivering specialized pharmaceutical products, including contraceptive devices, oncology treatments, vaccines, and injectable medications. The supplier's established presence in federal procurement markets and its central role in supporting military health operations underscore its significance as a critical vendor within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB25FPRF3?
SPE2DB25FPRF3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FPRF3 worth?
The government has obligated $10,415 on SPE2DB25FPRF3.
Is contract SPE2DB25FPRF3 an order under another contract?
Yes. SPE2DB25FPRF3 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRF3 competed?
The extent of competition for SPE2DB25FPRF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award